The aim of the "European Patients' Academy on Therapeutic Innovation" (EUPATI) is to provide scientifically reliable, objective, comprehensive information to patients on the research and development process of medicines. It will increase the capacity of patients and the lay public to be effective advocates and advisors, for example, in clinical trials, with regulatory authorities and in ethics committees.
On 6 March 2014, the UK National Liaison Team (NLT) launched the EUPATI National Platform (ENP) in the UK at a stakeholder event in Leeds. The ENP is open to all patients, patient advocates, patient organisations, academic institutions, clinical researchers, pharmaceutical companies, healthcare professionals, government officials and regulatory representatives, medical journalists etc.
The aim of the ENP is to continue the national conversation around patient involvement in medicines research and development, as well as to build the capacity of existing and future patient advocates by disseminating relevant educational and training tools. The UK has the highest number of patients taking part in the first cycle of the EUPATI patient expert training course, and the ENP hopes to work closely with them to grow the number of UK patient advocates, advisors and contributors.